CCL11 and metabolic dysfunction-associated steatotic liver disease: Contrary to the findings of Kong et al. [9], who reported undetectable CCL11 levels in hepatocytes and Kupffer cells in murine liver fibrosis models, Fan et al. demonstrated that hepatocytes in non-alcoholic fatty liver disease exhibit CCL11 expression through palmitate-mediated transcriptional activation [18].